The increasing cost of healthcare in the United States has accelerated the adoption of value-based medicine, which shifts a portion of the financial risk from the payer to the provider. This report, driven by a partnership between Capgemini Consulting and Omnicom Health Group, summarizes seminal research conducted across 866 physicians to better understand how providers are responding to the emerging value-based environment.
As providers develop new organizational structures to achieve their clinical and business goals, their needs continue to evolve. This study reveals how provider needs have changed, including now rating Real-World Evidence (RWE) as the most important data informing their prescribing decisions. The impact of these changes is significant, meaning the role and expectations of the pharmaceutical industry will need to evolve as well, in order to keep pace.
The insights uncovered in this research help provide initial guidance on developing a robust plan to meet the changing needs of your customers.
Organized Provider Care Delivery Models
Alternative Payment Models
Real World Evidence /
Patient Outcomes Data
Clinical Trial Data
Percent of respondents who anticipated relying on pharma for information on guidelines and quality metrics
Embrace Triple Aim
Speak the language
of quality and RWE
Invest in digital